Home » Stocks » LGND » Financials » Balance Sheet

Ligand Pharmaceuticals Inc. (LGND)

Stock Price: $118.96 USD -4.49 (-3.64%)
Updated Jul 29, 2021 4:00 PM EDT - Market closed
After-hours: $120.00 +1.04 (0.87%) Jul 29, 7:46 PM

Balance Sheet (Annual)

Numbers in millions USD. Fiscal year is January - December.
Year202020192018201720162015201420132012201120102009200820072006
Cash & Equivalents47.6271.5411720.6218.7597.4316112.9815.158.384.6917.4930.0976.81197
Short-Term Investments3649986791851261087.134.34-10.0019.3537.2051.9217.6013.45
Cash & Cash Equivalents4111,07079620614420516917.3215.1518.3824.0454.6982.0194.41211
Cash Growth-61.57%34.34%287.47%42.48%-29.63%21.59%873.42%14.34%-17.59%-23.53%-56.05%-33.31%-13.13%-55.19%-
Receivables56.8530.3955.8525.6014.706.1712.632.224.596.110.990.62--11.52
Inventory26.497.307.124.371.921.630.271.391.701.30----3.86
Other Current Assets6.0416.1011.161.512.181.913.663.952.396.4411.9912.8511.9215.549.52
Total Current Assets5011,12487123716321518524.8823.8232.2337.0268.1793.93110236
Property, Plant & Equipment37.1717.625.374.211.820.370.490.870.790.460.568.5212.902.875.55
Long-Term Investments---6.448.3529.73-------1.411.83
Goodwill and Intangibles79632633833430369.1467.5369.9168.1570.5612.952.525.38-83.08
Other Long-Term Assets28.5927.8846.9989.281261894.869.0611.5017.3325.0362.6059.2459.060.04
Total Long-Term Assets86237139043443928872.8779.8380.4488.3538.5473.6477.5263.3490.50
Total Assets1,3621,4951,26167160250325810510412175.56142171173326
Accounts Payable3.782.424.182.262.734.087.703.955.8511.078.6020.7214.6312.6812.26
Deferred Revenue29.442.143.29---2.092.202.864.712.558.4827.122.5560.53
Current Debt8.481.2626.43225213202-9.1114.8410.00--1.831.5339.92
Other Current Liabilities58.4111.1948.3512.0811.4916.7513.0013.6811.9017.8722.3522.9727.0434.2158.11
Total Current Liabilities10017.0082.2523922722322.7828.9435.4443.6433.4952.1770.6150.97171
Long-Term Debt448649610---196-13.4420.29--2.180.632.16
Other Long-Term Liabilities10561.757.7813.513.603.3314.9326.1628.8940.1338.5877.5596.6880.22113
Total Long-Term Liabilities55371161813.513.603.3321126.1642.3460.4138.5877.5598.8580.85116
Total Liabilities65372870025223122623455.1077.7810472.06130169132286
Total Debt4566506362252132021969.1128.2830.29--4.012.1642.07
Debt Growth-29.8%2.18%183.39%5.46%5.41%3.1%2050.71%-67.79%-6.63%---85.94%-94.88%-
Common Stock318367791798770662681718--687685669611891
Retained Earnings392400-229-401-431-429-659-671-683-682-692-682-680-582-863
Comprehensive Income-0.80-0.22-1.022.492.744.904.952.91--0.030.510.080.01-0.48
Shareholders' Equity71076756140034123726.3249.6126.498.19-4.853.74-10.3729.1227.35
Total Liabilities and Equity1,3621,4951,26165257246326010510411267.22133159161314
Net Cash / Debt-45.23420160-18.99-68.663.02-27.318.21-13.13-11.9024.0454.6978.0192.25169
Net Cash / Debt Growth-162.12%--72.34%----10.30%--56.05%-29.88%-15.44%-45.28%-
Net Cash Per Share-2.7922.097.57-0.90-3.300.15-1.340.40-0.66-0.611.232.904.905.6412.55
Working Capital4001,107788-1.85-64.08-8.11162-4.06-11.62-11.413.5315.9923.3258.9864.75
Book Value Per Share43.8440.3926.5119.0116.3811.991.292.441.330.42-0.250.20-0.651.782.04

Showing 15 of 26 years

11 more years are available